Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Clindamycin ABM
Active Ingredient: Clindamycin hydrochloride 177.515mg equivalent to Clindamycin 150mg
Dosage Form: Capsule
New Zealand Sponsor: ABM Pharma Limited
Manufacturer: Chanelle Medical Limited, County Galway, Ireland
Product: Coumadin
Active Ingredient: Warfarin sodium 1mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia
Product: Coumadin
Active Ingredient: Warfarin sodium 2mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia
Product: Coumadin
Active Ingredient: Warfarin sodium 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia
Product: Nodia
Active Ingredient: Loperamide hydrochloride 2mg
Dosage Form: Tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Maharashtra, India
Product: Your Pharmacy Nasal Congestion Relief PE (General Sale)
Active Ingredient: Phenylephrine hydrochloride 12.2mg
Dosage Form: Capsule
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Wrafton Laboratories Limited, Devon, United Kingdom
Product: Your Pharmacy Nasal Congestion Relief PE (Pharmacy only)
Active Ingredient: Phenylephrine hydrochloride 12.2mg
Dosage Form: Capsule
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Wrafton Laboratories Limited, Devon, United Kingdom
Dated this 31st day of August 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).